Compare DSP Focused Fund vs ICICI Prudential Focused Equity Fund
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.01 | 1.69 |
NAV | ₹54.56 | ₹95.10 |
Fund Started | 23 Apr 2010 | 15 Apr 2009 |
Fund Size | ₹2686.67 Cr | ₹14568.53 Cr |
Exit Load | Exit load of 1%, if redeemed within 1 month. | Exit load of 1% if redeemed within 1 year |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.01
1.69
NAV
₹54.56
₹95.10
Fund Started
23 Apr 2010
15 Apr 2009
Fund Size
₹2686.67 Cr
₹14568.53 Cr
Exit Load
Exit load of 1%, if redeemed within 1 month.
Exit load of 1% if redeemed within 1 year
1 Year | 7.38% | 16.33% |
3 Year | 18.86% | 22.21% |
5 Year | 13.07% | 19.63% |
1 Year
7.38%
16.33%
3 Year
18.86%
22.21%
5 Year
13.07%
19.63%
Equity | 93.26% | 97.46% |
Cash | 6.74% | 1.87% |
Equity
93.26%
97.46%
Cash
6.74%
1.87%
Top 10 Holdings |
|
|
Top 10 Holdings
ICICI Bank Ltd. | 6.72% |
Bajaj Finance Ltd. | 6.32% |
State Bank of India | 5.25% |
HDFC Bank Ltd. | 5.00% |
Axis Bank Ltd. | 4.87% |
Bharti Airtel Ltd. | 4.36% |
SBI Life Insurance Company Ltd. | 4.25% |
Cholamandalam Investment and Finance Company Ltd. | 4.10% |
Coforge Ltd. | 3.95% |
Ipca Laboratories Ltd. | 3.92% |
ICICI Bank Ltd. | 7.60% |
HDFC Bank Ltd. | 5.57% |
Infosys Ltd. | 4.83% |
Axis Bank Ltd. | 4.58% |
Sun Pharmaceutical Industries Ltd. | 4.52% |
Godrej Consumer Products Ltd. | 3.92% |
Titan Company Ltd. | 3.90% |
NTPC Ltd. | 3.73% |
Info Edge (India) Ltd. | 3.71% |
Britannia Industries Ltd. | 3.70% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme portfolio will largely consist of companies, which are amongst the top 200 companies by market capitalisation. The portfolio will limit exposure to companies beyond the top 200 companies by market capitalization upto 20% of the net asset value. The scheme will also have at least 95% of the invested amount across the top 25 holdings in the portfolio which excludes debt & money market securities. | The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap. |
Launch Date | 23 Apr 2010 | 15 Apr 2009 |
Description
The scheme portfolio will largely consist of companies, which are amongst the top 200 companies by market capitalisation. The portfolio will limit exposure to companies beyond the top 200 companies by market capitalization upto 20% of the net asset value. The scheme will also have at least 95% of the invested amount across the top 25 holdings in the portfolio which excludes debt & money market securities.
The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap.
Launch Date
23 Apr 2010
15 Apr 2009